Background There is limited information regarding the acceptability of injection devices for biological agents.
Objectives The primary objective of the study was to investigate patients’ perceptions on the acceptability of two devices delivering etanercept. The secondary objectives of the study were to explore whether patients’ attributes are associated with preferences.
Methods This was a multicentre, open-label, randomized, parallel-design study. Adult patients with psoriasis were randomized to receive etanercept 50 mg twice-weekly subcutaneously for 12 weeks, either as a pre-filled syringe or as a pre-filled pen. The primary outcome was the patient satisfaction at week ...
Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis is a post from: Skincare
Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis via BuzzBlazer.com
No comments:
Post a Comment